M. N. Mallory

Diaspirin cross-linked hemoglobin (DCLHb) in the treatment of severe traumatic hemorrhagic shock: a randomized controlled efficacy trial.

J. Runge, E. Sloan, M. Koenigsberg, 1999, Journal of the American Medical Association (JAMA).

The informed consent process and the use of the exception to informed consent in the clinical trial of diaspirin cross-linked hemoglobin (DCLHb) in severe traumatic hemorrhagic shock. DCLHb Traumatic Hemorrhagic Shock study group.

D. Gens, G. Rodman, E. Sloan, 1999, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.